Biologics Drug Discovery Services & Platforms Market
完整報告名稱與涵蓋範圍
Biologics Drug Discovery Services & Platforms Market Size, Share & Trends Analysis Report, By Service Type (Antibody Discovery and Generation, Target Validation and Assay Development, Lead Optimization and Humanization, Developability Assessment and Cell Line Development), By Discovery Technology (Transgenic Animal Platforms, Phage and Yeast Display, Single B-Cell and Microfluidic Screening, Computational and AI-Assisted Discovery), By Molecule Type (Monoclonal Antibodies, Bispecific and Multispecific Antibodies, Antibody Fragments and Fusion Proteins, Other Biologics), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The biologics drug discovery services and platforms market covers outsourced and licensed capabilities for discovering and optimising antibodies and other protein therapeutics, including target validation, antibody generation through transgenic, display, single B-cell or computational technologies, humanisation, lead optimisation and developability assessment through to cell line development. GMP manufacturing and clinical development services are excluded.
Biologics now account for a majority of new drug approvals by value, and the discovery task has become more complex as sponsors pursue bispecific and multispecific formats, conditionally active antibodies, and antibodies for difficult targets such as GPCRs and ion channels. Outsourcing has expanded because platform licensing offers access to validated transgenic animals, high-diversity libraries and microfluidic screening without capital investment, while integrated providers shorten timelines by linking discovery with cell line development and manufacturing. Computational design, high-throughput developability triage and functional screening at scale are the main technology shifts, and Chinese providers have become major suppliers of discovery capacity to Western sponsors.
North America, Europe and China dominate service demand and supply, with Japan and South Korea adding domestic capacity. Competition spans integrated biologics CDMOs, platform licensors, specialist antibody discovery companies and life science tool providers offering discovery services.
The InsightAce study provides US$ revenue forecasts for every service type, discovery technology, molecule type and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biologics Drug Discovery Services & Platforms Market Snapshot
Chapter 4. Global Biologics Drug Discovery Services & Platforms Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Antibody Discovery and Generation
5.2.2. Target Validation and Assay Development
5.2.3. Lead Optimization and Humanization
5.2.4. Developability Assessment and Cell Line Development
Chapter 6. Market Segmentation 2: By Discovery Technology Estimates & Trend Analysis
6.1. Discovery Technology & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Discovery Technology:
6.2.1. Transgenic Animal Platforms
6.2.2. Phage and Yeast Display
6.2.3. Single B-Cell and Microfluidic Screening
6.2.4. Computational and AI-Assisted Discovery
Chapter 7. Market Segmentation 3: By Molecule Type Estimates & Trend Analysis
7.1. Molecule Type & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Molecule Type:
7.2.1. Monoclonal Antibodies
7.2.2. Bispecific and Multispecific Antibodies
7.2.3. Antibody Fragments and Fusion Proteins
7.2.4. Other Biologics
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Academic and Research Institutes
Chapter 9. Biologics Drug Discovery Services & Platforms Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. WuXi Biologics (Cayman) Inc.
11.2. AbCellera Biologics Inc.
11.3. Charles River Laboratories International, Inc.
11.4. Twist Bioscience Corporation
11.5. Abzena Ltd.
11.6. Lonza Group AG
11.7. Evotec SE
11.8. GenScript ProBio
11.9. Alloy Therapeutics, Inc.
11.10. Ligand Pharmaceuticals (OmniAb)
11.11. Adimab, LLC
11.12. Sino Biological, Inc.
11.13. Curia Global, Inc.
11.14. Bio-Techne Corporation
11.15. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Biologics Drug Discovery Services & Platforms Market Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. Global Biologics Drug Discovery Services & Platforms Market Segmentation and Scope Overview
Table 2. Global Biologics Drug Discovery Services & Platforms Market Revenue Forecast by Discovery Technology, 2026-2035 (US$ Mn)
Figure 2. Global Biologics Drug Discovery Services & Platforms Market Share by Service Type, 2026 & 2035
Table 3. Global Biologics Drug Discovery Services & Platforms Market Revenue Forecast by Molecule Type, 2026-2035 (US$ Mn)
Figure 3. Biologics Discovery Technology Comparison: Transgenic, Display, Single B-Cell and Computational
Table 4. Global Biologics Drug Discovery Services & Platforms Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Bispecific and Multispecific Discovery Programs by Format and Sponsor Type
Table 5. Global Biologics Drug Discovery Services & Platforms Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Biologics Drug Discovery Services & Platforms Growth Opportunity Analysis
Table 6. North America Biologics Drug Discovery Services & Platforms Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Biologics Drug Discovery Services & Platforms Market Participants
Table 7. Europe Biologics Drug Discovery Services & Platforms Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Biologics Drug Discovery Services & Platforms Market
Table 8. Asia Pacific Biologics Drug Discovery Services & Platforms Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Outsourcing Penetration and Provider Concentration in Antibody Discovery
Table 9. Strategic Developments of Leading Biologics Drug Discovery Services & Platforms Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們